From 1 January 2027, Singapore’s Chronic Disease Management Programme (CDMP) has expanded to include two common thyroid conditions: hyperthyroidism and hypothyroidism.
Announced by the Ministry of Health (MOH), this change allows eligible patients to use MediSave and receive applicable Community Health Assist Scheme (CHAS) subsidies for ongoing thyroid treatment and management.
The update is part of broader changes to Singapore’s healthcare financing schemes, aimed at making long-term medical care more affordable.
The thyroid is a small, butterfly-shaped gland located in the neck. It produces hormones that regulate metabolism, energy levels, heart rate and body temperature.
When the thyroid produces too much or too little hormone, it can affect several functions throughout the body.
Two common thyroid conditions are:
| Hyperthyroidism (Overactive Thyroid) | Hypothyroidism (Underactive Thyroid) |
|---|---|
| Unexplained weight loss | Unexplained weight gain |
| Rapid heartbeat or palpitations | Tiredness and low energy |
| Increased sweating | Increased sensitivity to cold |
| Nervousness or anxiety | Dry skin and constipation |
| Difficulty sleeping | Slower thinking or concentration difficulties |
Symptoms may develop gradually and can sometimes be mistaken for stress, ageing or lifestyle-related changes.
A doctor may recommend thyroid function blood tests, including thyroid-stimulating hormone (TSH) and thyroid hormone measurements, to assess thyroid function.
Both conditions often require ongoing monitoring and, depending on the diagnosis, medication or other treatment.
Previously, the Chronic Disease Management Programme covered conditions such as diabetes, hypertension and high cholesterol.
From January 2027, hyperthyroidism and hypothyroidism have been added to the list of approved CDMP conditions.
This means eligible patients can use MediSave for qualifying outpatient care associated with these conditions at participating MediSave-accredited healthcare providers.
Depending on the treatment plan, eligible expenses may include consultations, prescribed medications and recommended investigations for ongoing thyroid management.
Alongside the expansion of CDMP coverage, MOH has increased the annual MediSave withdrawal limits for chronic disease management and selected preventive care.
The previous MediSave500/700 scheme has also been renamed MediSave Chronic and Preventive Care.
| Patient Category | Previous Annual Limit | From January 2027 |
|---|---|---|
| Patients without complex chronic conditions | $500 | $700 |
| Patients with complex chronic conditions | $700 | $1,000 |
Patients managing two or more different CDMP conditions, or a CDMP condition with recognised complications, may qualify for the higher $1,000 annual limit.
These limits apply to the overall scheme and are not separate allowances for each medical condition.
For patients requiring regular thyroid monitoring, the expanded coverage may help reduce out-of-pocket expenses over time.
Thyroid conditions can affect daily energy levels, body weight, heart rate and overall wellbeing. However, symptoms alone are not enough to confirm a thyroid disorder.
Early medical assessment and appropriate thyroid function testing can help identify underlying problems and guide treatment.
For individuals already diagnosed with hyperthyroidism or hypothyroidism, regular follow-up appointments are important to monitor thyroid hormone levels and adjust treatment when necessary.
At Healthsprings Medical Clinics, our doctors provide general medical consultations and can assess symptoms that may be associated with thyroid disorders.
If you are experiencing persistent fatigue, unexplained weight changes or other concerns about your thyroid health, speak with our medical team for an assessment.
Contact Healthsprings Medical Clinics to arrange a consultation.
Newsletter
